House Bill, 89th Legislature, Regular Session (2025)
HB 3785
Relating to labeling requirements for compounded drug products.
Filed by Rep. Gervin-Hawkins (D).
How far it got in 2025
Got a committee hearing; never left committee
Last official action April 28, 2025.
Who testified
Who signed up to testify at each committee hearing, and where they stood, from the committee's official witness list.
House Public Health, April 14, 2025
Official witness list3 for, 5 against, 4 on2 spoke at the hearing; the rest registered a position or sent written testimony. “On” means neither for nor against, often an agency answering questions.
Organizations represented (9)
- Texas pharmacy associationregistered lobby client2 against
- Texas State Board of Pharmacy2 on
- AARP Texasfor
- American Diabetes Associationregistered lobby clienton
- Pharmacy boardon
- Richie's Specialty Pharmacyagainst
- Texas Federation of Drug Storesregistered lobby clientagainst
- Texas Healthcare and Bioscience Instituteregistered lobby clientfor
- Texas Pharmacy Business Council/American Pharmaciesagainst
1 person representing themselves
For (1): Deline, Steven
Names appear as printed on the official list. “Registered lobby client” means the organization's name matches a client in 2025 lobby registrations filed with the Texas Ethics Commission; organizations whose names are spelled differently there aren't marked.
We keep a summary of each 2025 bill. Its full history, text, amendments, and votes are on Texas Legislature Online.